Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015
Go back to Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015| Regeneron (NASDAQ: REGN) | Delayed: 827.72 -15.75 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $843.47 | 52 Week High | $592.36 | |||
| Open | $840.05 | 52 Week Low | $325.35 | |||
| Day High | $841.54 | P/E | 217.25 | |||
| Day Low | $825.83 | EPS | $3.81 | |||
| Volume | 561,170 | |||||
| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 14.93 -0.12 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.05 | 52 Week High | $5.58 | |||
| Open | $14.90 | 52 Week Low | $3.60 | |||
| Day High | $14.97 | P/E | N/A | |||
| Day Low | $14.86 | EPS | $0.00 | |||
| Volume | 8,277,863 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 44.24 -0.09 (0.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.33 | 52 Week High | $44.76 | |||
| Open | $44.17 | 52 Week Low | $36.81 | |||
| Day High | $44.36 | P/E | N/A | |||
| Day Low | $44.03 | EPS | $0.00 | |||
| Volume | 1,695,048 | |||||
